Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Marqibo with Bendamustine and Rituximab in Indolent NHL
NCT02257242Phase 1Completed
- Sponsor
- Brown University
- Start
- May 2017
- Primary completion
- Aug 2020
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of vincristine in B-cell non-Hodgkin lymphoma, sponsored by Brown University. Started May 2017; status: completed.
02
Drugs
vincristine
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT02257242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02257242.